“Parkinson’s Disease-Associated Mutant LRRK2-Mediated Inhibition of miRNA Activity is Antagonized by TRIM32” has been published in the journal Molecular Neurobiology. This work was supported in part by JPND through the 3DPD project, selected in the 2015 JPco-fuND call and the SynSpread project, selected in the 2013 JPND Cross-Disease Analysis call.
Category Archives: JPND Publications
“Pre-Clinical Evaluation Of A Lentiviral Vector For Huntingtin Silencing” has been published in the journal Molecular Therapy: Methods & Clinical Development. This work was supported in part by JPND through the ModelPolyQ project, selected in the 2015 JPco-fuND call.
“Deletion of exons 9 and 10 of the Presenilin 1 gene in a patient with Early-onset Alzheimer Disease generates longer amyloid seeds” has been published in the journal Neurobiology of Disease. This work was supported in part by JPND through the PERADES project, selected in the 2012 Risk Factors call.
“Progranulin functions as a cathepsin D chaperone to stimulate axonal outgrowth in vivo” has been published in the journal Human Molecular Genetics. This work was supported in part by JPND through the STRENGTH and RiMod-FTD projects, selected in the 2012 Risk Factors call.
“Modelling amyotrophic lateral sclerosis: progress and possibilities” has been published in the journal Disease Models & Mechanisms. This work was supported in part by JPND through the STRENGTH and RiMod-FTD projects, selected in the 2012 Risk Factors call.
“Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria” has been published in the journal Movement Disorders. This work was supported in part by JPND through the ASAP SynTau project, selected in the 2016 Brain Imaging Working Groups call.
“The biological function of the cellular prion protein: an update” has been published in the journal BMC Biology. This work was supported in part by JPND through the CureALS and REfrAME projects, selected in the 2015 JPco-fuND call.
“Validation of qPCR reference genes in lymphocytes from patients with amyotrophic lateral sclerosis” has been published in the journal PLOS Medicine. This work was supported in part by JPND through the SOPHIA project, selected in the 2011 Biomarkers call.
“Therapeutic Strategies Under Development Targeting Inflammatory Mechanisms in Amyotrophic Lateral Sclerosis” has been published in Molecular Neurobiology. This work was supported in part by JPND through the DAMNDPATHS project, selected in the 2013 Cross-Disease Analysis call.
“Discovery and systematic functional validation of Parkinson’s disease genes from exome sequencing (S1.003)” has been published in Neurology. This work was supported in part by JPND through the 3DMiniBrain project, selected in the 2015 JPco-fuND call.